| miR-9 |
drug |
4 |
4 |
microRNA-9, microRNA-9/9* |
| miRBase |
drug |
2 |
1 |
|
| miRNA |
drug |
10 |
8 |
mature miRNA, miRNAs, microRNA, over-expressed miRNAs, upregulated miRNAs |
| miRNA expression |
phenotype |
2 |
1 |
miRNA levels |
| miRNAs |
drug |
3 |
2 |
microRNAs |
| mismatch negativity |
phenotype |
2 |
1 |
MMN, event related potential component |
| mismatch repair defects |
phenotype |
2 |
1 |
|
| missense variants |
variant |
11 |
6 |
NonSyn, missense mental retardation–causing variant, missense variants, putative disease-causing missense variant, single-base substitution missense variants |
| missing heritability |
phenotype |
6 |
5 |
missing heritability, unexplained heritability |
| Missouri Adolescent Female Twin Study |
cohort |
6 |
1 |
MOAFTS |
| misuse |
phenotype |
4 |
1 |
substance misuse |
| Mitochondria |
phenotype |
2 |
2 |
|
| mitochondrial dysfunction |
phenotype |
5 |
2 |
impaired mitochondrial functioning |
| mitochondrial function |
phenotype |
4 |
1 |
|
| mitomycin C |
drug |
2 |
— |
Mitomycin C (Sigma) |
| mitotic recombination |
phenotype |
2 |
1 |
|
| MiXeR |
drug |
3 |
2 |
MiXeR v1.315 |
| MKI67 |
gene |
6 |
— |
Ki-67, Ki-67 antigen, Ki67 |
| MLH1 |
gene |
5 |
1 |
|
| MMP9 |
gene |
6 |
2 |
MMP-9, matrix metallopeptidase 9, matrix metalloproteinase-9 |
